נאזונקס תרסיס לאף

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

MOMETASONE FUROATE 50 MCG/DOSE

Pieejams no:

MERCK SHARP & DOHME ISRAEL LTD

ATĶ kods:

D07AC13

Zāļu forma:

SOLUTION

Ievadīšanas:

NASAL

Ražojis:

SCHERING-PLOUGH LAB.NV BELGIUM

Ārstniecības grupa:

MOMETASONE

Ārstēšanas norādes:

In adults and children 3 years of age and older to treat the symptoms of seasonal or perennial rhinitis. In patients 12 years old and above who have a history of moderate to severe symptoms of seasonal allergic rhinitis prophylactic treatment with Nasonex Aqueous Nasal Spary is recommended 2- 4 weeks prior to the anticipated start of the pollen season.

Autorizācija datums:

2013-03-01